r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

AF

Annette F. Favorite

Insider · Sr. VP & Chief HR Officer · WST

Annette F. Favorite files insider transactions with the SEC as a sr. vp & chief hr officer of West Pharmaceutical Services. We hold 2 disclosed purchases and sales filed since 7 October 2015, 1 of them in the last 90 days.

  • Files forWST
  • Disclosed buys and sells2 in all, 1 in the last 90 days
  • Last disclosure10 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 5 October 2015 — 8 September 2026Sr. VP & Chief HR Officer · West Pharmaceutical Services 79 Form 4 lines · source: SEC Form 4

Every transaction

79 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
79 of 79 shown
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services2,817 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketWest Pharmaceutical Services2,817 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services2,818 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketWest Pharmaceutical Services2,818 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services2,500 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketWest Pharmaceutical Services2,500 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative2,817 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative2,818 sharesup +2.5%up +0.6%
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative2,500 sharesup +2.5%up +0.6%
27 Apr 202629 Apr 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services2,817 sharesup +14.6%up +17.2%
27 Apr 202629 Apr 2026SEC Form 42 dsold on the open marketWest Pharmaceutical Services2,817 sharesup +14.6%up +17.2%
27 Apr 202629 Apr 2026SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative2,817 sharesup +14.6%up +17.2%
1 Mar 20263 Mar 2026SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative720 sharesup +36.1%up +37.7%
1 Mar 20263 Mar 2026SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative1,712 sharesup +36.1%up +37.7%
1 Mar 20263 Mar 2026SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative720 sharesup +36.1%up +37.7%
1 Mar 20263 Mar 2026SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative1,712 sharesup +36.1%up +37.7%
18 Feb 202619 Feb 2026SEC Form 41 dexercised options overnot a tradeWest Pharmaceutical Services135 sharesup +39.5%up +42.0%
18 Feb 202619 Feb 2026SEC Form 41 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative135 sharesup +39.5%up +42.0%
18 Feb 202619 Feb 2026SEC Form 41 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services36 sharesup +39.5%up +42.0%
18 Feb 202619 Feb 2026SEC Form 41 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative135 sharesup +39.5%up +42.0%
18 Feb 202619 Feb 2026SEC Form 41 dexercised options overnot a tradeWest Pharmaceutical Services135 sharesup +39.5%up +42.0%
18 Feb 202619 Feb 2026SEC Form 41 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services36 sharesup +39.5%up +42.0%
17 Feb 202619 Feb 2026SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services442 sharesup +42.4%up +42.0%
17 Feb 202619 Feb 2026SEC Form 42 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services150 sharesup +42.4%up +42.0%
17 Feb 202619 Feb 2026SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services442 sharesup +42.4%up +42.0%
17 Feb 202619 Feb 2026SEC Form 42 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services150 sharesup +42.4%up +42.0%
18 Feb 202520 Feb 2025SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative1,251 sharesup +64.1%up +70.0%
18 Feb 202520 Feb 2025SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative542 sharesup +64.1%up +70.0%
18 Feb 202520 Feb 2025SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services246 sharesup +64.1%up +70.0%
18 Feb 202520 Feb 2025SEC Form 42 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services84 sharesup +64.1%up +70.0%
20 Feb 202422 Feb 2024SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative2,597 sharesdown −1.1%down −3.8%
20 Feb 202422 Feb 2024SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services541 sharesdown −1.1%down −3.8%
11 Dec 202313 Dec 2023SEC Form 42 dgave awaynot a tradeWest Pharmaceutical Services584 sharesup +0.6%down −3.7%
30 Aug 20231 Sep 2023SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative2,000 sharesdown −15.4%down −15.1%
30 Aug 20231 Sep 2023SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services2,000 sharesdown −15.4%down −15.1%
30 Aug 20231 Sep 2023SEC Form 42 dsold on the open marketWest Pharmaceutical Services760 sharesdown −15.4%down −15.1%
30 Aug 20231 Sep 2023SEC Form 42 dsold on the open marketWest Pharmaceutical Services1,240 sharesdown −15.4%down −15.1%
1 May 20232 May 2023SEC Form 41 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative13,012 sharesdown −5.4%down −6.3%
1 May 20232 May 2023SEC Form 41 dexercised options overnot a tradeWest Pharmaceutical Services13,012 sharesdown −5.4%down −6.3%
1 May 20232 May 2023SEC Form 41 dsold on the open marketWest Pharmaceutical Services9,425 sharesdown −5.4%down −6.3%
1 May 20232 May 2023SEC Form 41 dsold on the open marketWest Pharmaceutical Services2,687 sharesdown −5.4%down −6.3%
1 May 20232 May 2023SEC Form 41 dsold on the open marketWest Pharmaceutical Services900 sharesdown −5.4%down −6.3%
21 Feb 202323 Feb 2023SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative2,988 sharesup +12.9%up +11.0%
21 Feb 202323 Feb 2023SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services1,740 sharesup +12.9%up +11.0%
22 Feb 202224 Feb 2022SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services2,490 sharesdown −6.2%down −8.5%
22 Feb 202224 Feb 2022SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative3,108 sharesdown −6.2%down −8.5%
23 Feb 202125 Feb 2021SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative3,968 sharesup +26.2%up +24.7%
22 Feb 202124 Feb 2021SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services2,438 sharesup +27.0%up +24.1%
27 Apr 202029 Apr 2020SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative4,728 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Servicesderivative9,464 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services4,728 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dexercised options overnot a tradeWest Pharmaceutical Services9,464 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dsold on the open marketWest Pharmaceutical Services2,600 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dsold on the open marketWest Pharmaceutical Services5,431 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dsold on the open marketWest Pharmaceutical Services4,261 sharesup +75.0%up +82.6%
27 Apr 202029 Apr 2020SEC Form 42 dsold on the open marketWest Pharmaceutical Services1,900 sharesup +75.0%up +82.6%
23 Feb 202025 Feb 2020SEC Form 42 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services42 sharesup +103.5%up +113.0%
18 Feb 202020 Feb 2020SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative5,740 sharesup +99.9%up +101.7%
18 Feb 202020 Feb 2020SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services1,320 sharesup +99.9%up +101.7%
7 Oct 20199 Oct 2019SEC Form 42 dhad shares withheld for taxnot a tradeWest Pharmaceutical Services1,355 sharesup +146.1%up +146.1%
1 Mar 20195 Mar 2019SEC Form 44 dwas grantednot a tradeWest Pharmaceutical Services1,332 sharesup +226.2%up +231.4%
19 Feb 201921 Feb 2019SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative8,160 sharesup +237.8%up +233.5%
19 Feb 201921 Feb 2019SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services863 sharesup +237.8%up +233.5%
20 Feb 201822 Feb 2018SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative10,024 sharesup +286.2%up +299.1%
13 Feb 201815 Feb 2018SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services1,229 sharesup +272.3%up +291.9%
13 Feb 201815 Feb 2018SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services1,082 sharesup +272.3%up +291.9%
29 Dec 20173 Jan 2018SEC Form 45 dwas grantednot a tradeWest Pharmaceutical Services5 sharesup +250.9%up +247.6%
21 Feb 201722 Feb 2017SEC Form 41 dwas grantednot a tradeWest Pharmaceutical Servicesderivative10,452 sharesup +314.8%up +315.9%
14 Feb 201716 Feb 2017SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services520 sharesup +298.3%up +321.9%
14 Feb 201716 Feb 2017SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services2,372 sharesup +298.3%up +321.9%
30 Dec 20163 Jan 2017SEC Form 44 dwas grantednot a tradeWest Pharmaceutical Services5 sharesup +308.1%up +311.8%
16 Dec 201619 Dec 2016SEC Form 43 dwas grantednot a tradeWest Pharmaceutical Services5 sharesup +309.1%up +307.3%
2 Dec 20165 Dec 2016SEC Form 43 dwas grantednot a tradeWest Pharmaceutical Services6 sharesup +329.7%up +325.0%
18 Nov 201621 Nov 2016SEC Form 43 dwas grantednot a tradeWest Pharmaceutical Services0 sharesup +332.0%up +331.1%
23 Feb 201625 Feb 2016SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services730 sharesup +480.5%up +454.0%
23 Feb 201625 Feb 2016SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative13,012 sharesup +480.5%up +454.0%
5 Oct 20157 Oct 2015SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Services4,538 sharesup +528.5%up +536.1%
5 Oct 20157 Oct 2015SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative9,464 sharesup +528.5%up +536.1%
5 Oct 20157 Oct 2015SEC Form 42 dwas grantednot a tradeWest Pharmaceutical Servicesderivative4,728 sharesup +528.5%up +536.1%

Both percentages are the stock’s move, not Annette F. Favorite’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 79 of the 79 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.